Physician profile
Amber Bishop
NPI 1265791495
$248.83
in general payments reported to CMS, 2019-2025
8 companies · $39.04 in 2025
The $39.04 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.00 · 2020: $32.68 · 2021: $82.87 · 2023: $56.13 · 2024: $9.11 · 2025: $39.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $78.56 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $37.64 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $34.56 | 2023 | Inpefa |
| Pfizer INC. | $28.35 | 2019-2020 | |
| Sanofi Pasteur INC. | $23.07 | 2025 | |
| Sobi, INC | $21.57 | 2023 | |
| Merck Sharp & Dohme LLC | $15.97 | 2025 | Enflonsia, Vaxneuvance, Gardasil 9 |
| Corium, LLC | $9.11 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.